“EXPLORATION OF HYDROXYL SUBSTITUTED REGORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA THROUGH MOLECULAR DOCKING” (2026) Frontier in Medical and Health Research, 4(3), pp. 3863–3874. Available at: https://fmhr.net/index.php/fmhr/article/view/3740 (Accessed: 9 November 2026).